Sofinnova Investments’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-39,589
| Closed | -$6.81M | – | 80 |
|
|
2021
Q3 | $6.81M | Sell |
39,589
-194,049
| -83% | -$33.4M | 0.4% | 42 |
|
|
2021
Q2 | $29.3M | Buy |
233,638
+55,100
| +31% | +$6.91M | 1.69% | 13 |
|
|
2021
Q1 | $24.2M | Buy |
178,538
+141,850
| +387% | +$19.2M | 1.46% | 17 |
|
|
2020
Q4 | $4.69M | Sell |
36,688
-22,858
| -38% | -$2.92M | 0.28% | 48 |
|
|
2020
Q3 | $6.7M | Sell |
59,546
-157,844
| -73% | -$17.8M | 0.5% | 34 |
|
|
2020
Q2 | $20.7M | Buy |
217,390
+52,230
| +32% | +$4.98M | 1.31% | 20 |
|
|
2020
Q1 | $14.8M | Buy |
165,160
+18,128
| +12% | +$1.63M | 1.37% | 17 |
|
|
2019
Q4 | $7.8M | Sell |
147,032
-261,230
| -64% | -$13.9M | 0.56% | 33 |
|
|
2019
Q3 | $16.1M | Buy |
408,262
+167,219
| +69% | +$6.61M | 1.46% | 20 |
|
|
2019
Q2 | $9.9M | Buy |
+241,043
| New | +$9.9M | 0.91% | 26 |
|